Paliperidone Tablet, Extended Release
Product Images NDC 65162-281

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paliperidone (NDC 65162-281). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (Paliperidone Extended Release Tablets 1)

FDA Label Image

1.5 mg Label (Paliperidone Extended Release Tablets 2)

1.5 mg Label (Paliperidone Extended Release Tablets 2)
This is a description for the medication with the NDC code 65162-280-03, which contains extended-release tablets of the drug Paliperidone. It is advised to take the tablets by swallowing them whole and not crushing or dividing them. Each tablet has 1.5 mg of paliperdone. The dosage should be checked in the package insert or full prescribing information. The medication should be kept in a tight container, protected from moisture, and stored at a temperature between 20 to 25°C. This medication is distributed by Amneal Pharmaceuticals LLC in Bridgenaler, NJ. Lot Number and Exp. Date are printed on the package.*
FDA Label Image

3 mg Label (Paliperidone Extended Release Tablets 3)

3 mg Label (Paliperidone Extended Release Tablets 3)
This is a medication called Paliperidone, available in extended-release tablets. Each tablet contains 3 mg of Paliperidone, and it is dispensed in tight containers. The recommended dosage information can be found on the package insert. It is distributed by Amneal Pharmaceuticals and must be stored in a dry place, out of reach of children, at a temperature between 20 and 25C. The Lot No. and Exp. Date are printed on the packaging.*
FDA Label Image

6 mg Label (Paliperidone Extended Release Tablets 4)

6 mg Label (Paliperidone Extended Release Tablets 4)
This is a description of Paliperidone, an extended-release tablet for oral use. Each tablet contains 6 mg of Paliperidone, USP. It must be swallowed whole and should not be crushed or chewed. The package insert must be consulted for full prescribing information because the dosage of the medication varies depending on the individual. The medication should be dispensed in a tight container and kept at a temperature of 20-25°C, with excursions permitted between 15-30°C. The medication should be protected from moisture and kept out of reach of children. It is distributed by Amneal Pharmaceuticals LLC located in NJ 08807. There is also a non-varnish area for the Lot No. and Exp. Date.*
FDA Label Image

9 mg Label (Paliperidone Extended Release Tablets 5)

9 mg Label (Paliperidone Extended Release Tablets 5)
This is a description of medication called Paliperidone in the form of extended-release tablets. Each tablet contains 9 mg of Paliperidone, USP. It is recommended to take the tablets once a day and should be swallowed whole, not divided, crushed or chewed. For proper usage guidelines and dosage instructions, consult the package insert or full prescribing information. The medication should be kept in a tightly sealed container and stored at a temperature of 20 to 25°C. Moisture needs to be avoided and the medication needs to be out of reach of children. The NDC code is 65162-283-03 and it is distributed by Amneal Pharmaceuticals in Bridgewater, NJ. An area on the packaging is also provided for recording the product lot number and expiration date.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.